Top News

  • LGBTQ+ conference proposals due tomorrow; get submission info

    Time is running out to submit a proposal for the 2022 LGBTQ+ Health Care Conference, which will be held March 24-26. The application deadline is December 17.

    The conference is a three-day event designed for healthcare professionals, learners, researchers, patients, community organizations and community members who seek to understand the unique health considerations and barriers to health care in the LGBTQ+ population.

    Back to Top ▲

  • IU plans to continue all health and safety measures into the new year

    COVID-19 cases are increasing in communities across the state, primarily due to the delta variant. Because of this, along with the approaching winter weather, Indiana University plans to continue all its health and safety measures to protect against the spread of COVID-19 heading into the spring 2022 semester.

    In IU Today, take a look at what this means for classes, masks, remote work, vaccines and more.

    Back to Top ▲

  • Happy Holidays from INScope; next issue arrives January 6

    INScope is taking a two-week break for the holiday season. Be sure to check your inbox on Thursday, January 6, for the first issue of 2022.

    Back to Top ▲

Research News

  • Triple negative breast cancer research findings published in prominent journal

    IU School of Medicine physician scientist Bryan Schneider, MD is the principal investigator of clinical trial BRE12-158, a randomized clinical study published in the prominent Journal of Clinical Oncology. The primary goal of the study is to compare survival in women with high-risk (those who did not fully respond to chemotherapy prior to surgery) triple negative breast cancer (TNBC) with a genomically directed therapy versus standard of care.

    The study found that in the adjuvant (following chemotherapy and surgery) setting, a single genomically directed therapy was not better than a current standard of care option, which was capecitabine.

    “Although this study did not prove genomically directed therapy was significantly superior alone, it did provide many advances for the treatment of high-risk triple negative breast cancer. We are thankful for the 200 patients and study teams across the United States who participated in this trial,” said Schneider, a researcher at the Vera Bradley Foundation Center for Breast Cancer Research at the IU Melvin and Bren Simon Comprehensive Cancer Center.

    For more on the research findings, visit the Newsroom.

    Back to Top ▲

Faculty and Staff News

  • Remembering Hal E. Broxmeyer, PhD

    The IU School of Medicine community lost a giant in the field of scientific research. Hal E. Broxmeyer, PhD, passed away on December 8. Dr. Broxmeyer’s research was instrumental in pioneering the field of cord blood transplantation.

    Dr. Broxmeyer was a distinguished professor, Mary Margaret Walther Professor Emeritus, professor of microbiology and immunology, and senior advisor to the director of the IU Simon Comprehensive Cancer Center.

    A native of Brooklyn, New York, Dr. Broxmeyer joined the faculty at IU School of Medicine in 1983. His innovations quickly made lasting impacts on the world of medicine—his work led to the first umbilical cord stem cell transplantation, which took place in Paris on October 6, 1988. Since then, more than 40,000 people worldwide have benefited from this procedure.

    “The first thing I knew about IU School of Medicine was Hal Broxmeyer,” said IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA. “His scientific bona fides were without peer—Hal was the only non-physician president of the American Society of Hematology and was an international leader in hematopoiesis. But on a personal level, he was a trusted source of wisdom and support for me. I feel fortunate to have called him a colleague and a friend, and I will miss him very much.”

    A strong believer in the collaborative pursuit of scientific principles and experiments, Dr. Broxmeyer would become the first director of the Walther Oncology Center, chair of the Department of Microbiology and Immunology and a pillar for the IU Simon Comprehensive Cancer Center—mentoring countless colleagues along the way.

    Dr. Broxmeyer’s obituary includes more details about his life and career.

    Back to Top ▲

  • Juneteenth will be a university holiday

    Indiana University President Pamela Whitten announced this week that IU will recognize Juneteenth as an official university holiday beginning in 2022.

    In a memo earlier this week, Whitten wrote, “In the new year, we’ll recognize June 19 together, for the first time, as a university community and honor the oldest nationally celebrated commemoration of the end of enslavement in the United States.”

    IU will honor Juneteenth annually, and on Monday, June 20, 2022, IU offices will be closed. It will be a paid university holiday for IU faculty and staff.

    Back to Top ▲

Opportunities

  • Cross Cultural Student Success Retreat is January 8

    Focused on providing unity and solidarity for student populations underrepresented in medicine, the Cross Cultural Student Success Retreat will be held from 10 am-2:30 pm, Saturday, January 8, and is open to all. The retreat will include tailored programming to meet the needs of first, second and third-year students. This event provides an opportunity for students to connect with each other, develop skills and strengthen relationships with support systems at IU School of Medicine. Learn more and register.

    Back to Top ▲

  • Save the date: Seminar to focus on legacy of medicine during the Holocaust

    The Association of American Medical Colleges will host the virtual seminar, “Legacy of Medicine During the Holocaust and its Contemporary Relevance,” on Thursday, January 27, from noon-1:15 pm.  The event will be presented by Hedy S. Wald, PhD, Alpert Medical School of Brown University, and Sabine Hildebrandt, MD, Harvard Medical School. Both Wald and Hildebrandt are commissioners of the Lancet Commission on Medicine and the Holocaust. The seminar will catalyze critical thinking on the relevance of the Holocaust for contemporary medicine and help health care trainees and professionals reflect on their core values in the service of humanistic and ethically responsible patient care. Register for the virtual seminar.

    Back to Top ▲

  • Medical students: MedSTAR and IMPRS applications due

    MedSTAR provides supported clinical and translational research opportunities for IU School of Medicine medical students. Targeted to MS2, MS3 and MS4 students, the program is a collaboration between IU School of Medicine and Indiana CTSI that seeks to strengthen and increase the cohort of physician-scientists in the workforce. The one-year fellowship allows medical students to be immersed in research support for one year of full-time mentored training. Applications are due December 31.

    The Indiana Medical Student Program for Research and Scholarship (IMPRS) facilitates IU School of Medicine medical student participation in various medical research and experiential opportunities, including laboratory, clinical, health research outcomes and community health education. To be eligible for the program, applicants must be current IU School of Medicine students in Phase 1 Year 1. Applications are due January 15. 

    Back to Top ▲

Partner News

  • Chalasani to lead IU Health Office of Academic Affairs

    Naga Chalasani, MD, the David W. Crabb Professor of Medicine and interim chair of the IU School of Medicine Department of Medicine, has been appointed to direct the IU Health Office of Academic Affairs. The appointment is effective on January 1, when he relinquishes the role of interim chair. In his new role, Chalasani will report to IU Health Chief Medical Executive David Ingram, MD.

    Chalasani will be responsible for directing the programs of the Office of Academic Affairs and developing its new strategic vision. He will provide broad oversight and leadership for the Cancer, Cardiovascular and Neurosciences Institutes in partnership with Ryan Nagy, MD, president of the IU Health Adult Academic Health Center, and the IU Health Office of Strategy.

    Back to Top ▲

Kudos